ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 3593

$1.45M Total Retail Price of All Prescriptions

Rank: 56 out of 3593

684 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 21,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,418 978 1 5
TRAMADOL HCL 1,303 757 2 17
SIMVASTATIN 1,230 832 3 1
POTASSIUM CHLORIDE 1,030 804 4 24
FUROSEMIDE 966 746 5 9
LISINOPRIL 930 570 6 2
GABAPENTIN 840 475 7 16
LEVOTHYROXINE SODIUM 772 607 8 4
TIZANIDINE HCL 732 367 9 120
CLONIDINE HCL 669 318 10 41
CARVEDILOL 607 486 11 23
TRAZODONE HCL 604 324 12 53
METOPROLOL TARTRATE 592 361 13 8
SPIRONOLACTONE 558 424 14 86
AMLODIPINE BESYLATE 544 379 15 3
LOSARTAN POTASSIUM 466 367 16 14
PROMETHAZINE HCL 422 174 R 17 142
HYDROCHLOROTHIAZIDE 412 251 18 10
HYDROXYZINE HCL 395 219 R 10 19 196
ROPINIROLE HCL 374 263 20 144
PRAVASTATIN SODIUM 355 293 21 13
AMOXICILLIN 331 227 22 128
CITALOPRAM HBR 326 244 23 25
METFORMIN HCL 304 216 24 6
CRESTOR 302 175 25 21
AMITRIPTYLINE HCL 298 170 R 26 90
NAMENDA 289 272 27 50
JANUVIA 289 231 27 81
SINGULAIR 288 216 29 77
ALLOPURINOL 286 243 30 35
DONEPEZIL HCL 269 264 31 31
TRIAMTERENE-HCTZ 234 118 32 66
WARFARIN SODIUM 230 217 33 18
TAMSULOSIN HCL 220 159 34 33
FAMOTIDINE 217 142 35 70
FLUTICASONE PROPIONATE 216 139 36 32
CARBAMAZEPINE 211 145 37 245
METOPROLOL SUCCINATE 206 179 38 19
LEVOFLOXACIN 199 143 39 116
BUPROPION XL 190 102 40 243
NEXIUM 189 107 41 36
MELOXICAM 185 108 42 29
LANTUS SOLOSTAR 182 121 43 122
METFORMIN HCL ER 180 136 44 67
ATENOLOL 177 96 45 11
CARBIDOPA-LEVODOPA 176 132 46 135
KLOR-CON 10 175 140 47 114
PROPRANOLOL HCL 175 131 47 181
OXYBUTYNIN CHLORIDE 175 158 47 104
NAPROXEN 172 84 50 68
MONTELUKAST SODIUM 166 116 51 151
CLOPIDOGREL 166 119 51 30
DIGOXIN 165 144 53 58
GENTAMICIN SULFATE 165 123 53 318
DOXEPIN HCL 159 119 55 284
CYMBALTA 157 74 56 73
PLAVIX 152 94 57 42
PEN NEEDLE 146 113 58 188
INSULIN SYRINGE 144 94 59 91
DOXYCYCLINE HYCLATE 144 85 59 141
GLYBURIDE 141 128 R 61 55
PREDNISONE 137 80 62 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 131 84 63 102
FENOFIBRATE 129 66 64 39
FLOVENT HFA 129 85 64 303
POLYETHYLENE GLYCOL 3350 125 92 66 143
LANTUS 123 92 67 57
ESTRADIOL 119 76 R 68 174
NITROSTAT 117 89 69 224
COMBIVENT 117 61 69 161
FINASTERIDE 114 110 71 79
DIOVAN 113 108 72 46
NITROGLYCERIN PATCH 110 101 73 212
TRIAMCINOLONE ACETONIDE 107 69 74 119
LIDODERM 104 67 75 78
HUMALOG 102 51 76 249
CYCLOBENZAPRINE HCL 102 55 R 76 72
RAMIPRIL 102 66 76 92
SERTRALINE HCL 100 71 79 28
BUPROPION HCL SR 100 48 79 207
KETOCONAZOLE 100 87 79 118
BUMETANIDE 98 84 82 148
MUPIROCIN 97 59 83 132
PREMARIN 96 65 R 84 204
VENLAFAXINE HCL 94 60 85 267
METHOCARBAMOL 93 16 R 86 185
PAROXETINE HCL 93 50 86 62
PROAIR HFA 92 55 88 54
CHLORTHALIDONE 89 50 89 227
LANSOPRAZOLE 88 67 90 113
NABUMETONE 86 70 91 251
FLUCONAZOLE 86 43 91 229
EVISTA 84 63 93 200
FLUOXETINE HCL 81 37 94 60
QUETIAPINE FUMARATE 81 42 94 89
NYSTATIN 77 59 96 167
ZETIA 77 46 96 110
ADVAIR DISKUS 75 37 98 47
INDAPAMIDE 73 55 99 263
HYDROXYZINE PAMOATE 73 29 R 99 369
ONGLYZA 73 60 99 221
METOCLOPRAMIDE HCL 72 35 102 145
SYNTHROID 72 64 102 51
RISPERIDONE 71 49 104 83
MIRTAZAPINE 71 71 104 64
IBUPROFEN 70 39 106 43
DIVALPROEX SODIUM 70 48 106 121
DOXAZOSIN MESYLATE 70 41 106 63
COLCRYS 69 65 109 336
PANTOPRAZOLE SODIUM 68 38 110 45
NOVOLOG 67 57 111 134
LOSARTAN-HYDROCHLOROTHIAZIDE 66 54 112 48
SYMBICORT 66 28 112 160
SUCRALFATE 66 43 112 237
ONDANSETRON HCL 65 46 115 396
TERCONAZOLE 61 43 116 426
MECLIZINE HCL 61 46 116 96
VENTOLIN HFA 61 18 116 80
ENALAPRIL MALEATE 60 47 119 38
AZITHROMYCIN 59 40 120 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 51 120 26
GLYBURIDE-METFORMIN HCL 58 43 R 122 95
MEGESTROL ACETATE 58 52 R 122 152
LACTULOSE 57 51 124 126
CIPROFLOXACIN HCL 53 41 125 52
HYDROCORTISONE 52 31 126 273
HUMULIN 70-30 52 38 126 215
VENLAFAXINE HCL ER 51 26 128 178
VERAPAMIL ER 50 43 129 99
AMOX TR-POTASSIUM CLAVULANATE 50 32 129 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.